A citation-based method for searching scientific literature

Galina S Bogatkevich, Anna Ludwicka-Bradley, Paul J Nietert, Tanjina Akter, Joanne van Ryn, Richard M Silver. Arthritis Rheum 2011
Times Cited: 76







List of co-cited articles
711 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Richard M Silver. Arthritis Rheum 2009
68
44

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
296
25


Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, Paul F Mercer, Y C Gary Lee, Naftali Kaminski, John Morser, Joseph M Post, Toby M Maher, Andrew G Nicholson,[...]. J Clin Invest 2009
221
17

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
D C Howell, N R Goldsack, R P Marshall, R J McAnulty, R Starke, G Purdy, G J Laurent, R C Chambers. Am J Pathol 2001
134
17

Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
David C J Howell, Robin H Johns, Joseph A Lasky, Bin Shan, Chris J Scotton, Geoffrey J Laurent, Rachel C Chambers. Am J Pathol 2005
159
15

Anticoagulant therapy for idiopathic pulmonary fibrosis.
Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki. Chest 2005
295
15



A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
14

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
14

Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.
Gerald S Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey E Lukashev, Paul H Weinreb, Kenneth J Simon, Kyungmin Hahm, Normand E Allaire, Nicola J Rinaldi,[...]. Am J Respir Crit Care Med 2008
275
13

Role of thrombin in pulmonary fibrosis.
N A Hernández-Rodríguez, A D Cambrey, N K Harrison, R C Chambers, A J Gray, A M Southcott, R M duBois, C M Black, M F Scully, R J McAnulty. Lancet 1995
109
13

Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.
R C Chambers, K Dabbagh, R J McAnulty, A J Gray, O P Blanc-Brude, G J Laurent. Biochem J 1998
124
11

Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.
Vidya Navaratnam, Andrew W Fogarty, Tricia McKeever, Norma Thompson, Gisli Jenkins, Simon R Johnson, Gerard Dolan, Maruti Kumaran, Kate Pointon, Richard B Hubbard. Thorax 2014
62
14

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R Seibold,[...]. J Rheumatol 2016
124
11

Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.
Barry S Shea, Clemens K Probst, Patricia L Brazee, Nicholas J Rotile, Francesco Blasi, Paul H Weinreb, Katharine E Black, David E Sosnovik, Elizabeth M Van Cott, Shelia M Violette,[...]. JCI Insight 2017
39
23

Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.
R Gisli Jenkins, Xiao Su, George Su, Christopher J Scotton, Eric Camerer, Geoffrey J Laurent, George E Davis, Rachel C Chambers, Michael A Matthay, Dean Sheppard. J Clin Invest 2006
231
10

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Andrew M Tager, Peter LaCamera, Barry S Shea, Gabriele S Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy Polosukhin, John Wain, Banu A Karimi-Shah, Nancy D Kim,[...]. Nat Med 2008
490
10

Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
I Kotani, A Sato, H Hayakawa, T Urano, Y Takada, A Takada. Thromb Res 1995
144
10

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
9

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
H Yasui, E C Gabazza, S Tamaki, T Kobayashi, O Hataji, H Yuda, S Shimizu, K Suzuki, Y Adachi, O Taguchi. Am J Respir Crit Care Med 2001
118
9


Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
9

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler. Ann Rheum Dis 2015
218
9

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
913
9

Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Cong Lin, Janwillem Duitman, Joost Daalhuisen, Marieke Ten Brink, Jan von der Thüsen, Tom van der Poll, Keren Borensztajn, C Arnold Spek. Thorax 2014
34
20

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
338
9

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
380
9

Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.
R M Silver, D A Wilson, T Akter, I Atanelishvili, J T Huggins, K Kajdasz, K B Highland, P J Nietert, G S Bogatkevich. ACR Open Rheumatol 2019
9
77

Systemic sclerosis: a prototypic multisystem fibrotic disorder.
John Varga, David Abraham. J Clin Invest 2007
767
7

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara Jones, Rajesh Jagirdar, Tracy R Luckhardt, Jeffrey C Horowitz, Subramaniam Pennathur, Fernando J Martinez, Victor J Thannickal. Nat Med 2009
569
7

PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.
Jun Wei, Asish K Ghosh, Jennifer L Sargent, Kazuhiro Komura, Minghua Wu, Qi-Quan Huang, Manu Jain, Michael L Whitfield, Carol Feghali-Bostwick, John Varga. PLoS One 2010
123
7

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
J S Munger, X Huang, H Kawakatsu, M J Griffiths, S L Dalton, J Wu, J F Pittet, N Kaminski, C Garat, M A Matthay,[...]. Cell 1999
7

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
921
7

Coagulation cascade proteinases in lung injury and fibrosis.
Rachel C Chambers, Chris J Scotton. Proc Am Thorac Soc 2012
53
11


Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
Jun Wei, Feng Fang, Anna P Lam, Jennifer L Sargent, Emily Hamburg, Monique E Hinchcliff, Cara J Gottardi, Radhika Atit, Michael L Whitfield, John Varga. Arthritis Rheum 2012
155
7

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
367
7

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
Michael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler, Toby M Maher. Eur Respir J 2016
42
14

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
379
7


Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
Andreas Günther, Norbert Lübke, Monika Ermert, Ralph T Schermuly, Norbert Weissmann, Andreas Breithecker, Philipp Markart, Clemens Ruppert, Karin Quanz, Leander Ermert,[...]. Am J Respir Crit Care Med 2003
127
6

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
Craig E Daniels, Joseph A Lasky, Andrew H Limper, Kathleen Mieras, Edith Gabor, Darrell R Schroeder. Am J Respir Crit Care Med 2010
261
6

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.
Fei Liu, Justin D Mih, Barry S Shea, Alvin T Kho, Asma S Sharif, Andrew M Tager, Daniel J Tschumperlin. J Cell Biol 2010
431
6

Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.
Yoshihide Asano, Hironobu Ihn, Kenichi Yamane, Masatoshi Jinnin, Yoshihiro Mimura, Kunihiko Tamaki. J Immunol 2005
164
6

Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
Flavia V Castelino, Jon Seiders, Gretchen Bain, Sarah F Brooks, Christopher D King, James S Swaney, Daniel S Lorrain, Jerold Chun, Andrew D Luster, Andrew M Tager. Arthritis Rheum 2011
114
6

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
Joanne van Ryn, Joachim Stangier, Sebastian Haertter, Karl-Heinz Liesenfeld, Wolfgang Wienen, Martin Feuring, Andreas Clemens. Thromb Haemost 2010
6

Coagulation cascade proteases and tissue fibrosis.
R C Chambers, G J Laurent. Biochem Soc Trans 2002
75
6

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.